Literature DB >> 11297363

Production of an antifungal antibiotic by Streptomyces aburaviensis 1DA-28.

S Raytapadar1, A K Paul.   

Abstract

A broad-spectrum antifungal Streptomyces isolate, 1DA-28, from Indian soil has been characterized and identified as Streptomyces aburaviensis var. ablastmyceticus (MTCC 2469). Nutritional and cultural conditions for the production of antibiotic by this organism under shake-flask conditions have been determined. Antibiotic production in synthetic medium reached the maximum on the 5th day of incubation at 30 degreesC. Glucose and starch were found to be the best carbon sources while NH4NO3 was preferred as nitrogen source. Optimum temperature and pH for antibiotic production were 32 degreesC and 7.4, respectively. Phosphate at a concentration sub-optimal for growth enhanced antibiotic production. Supplementation of medium with casein hydrolysate improved both growth and antibiotic titre but yeast extract exhibited marked inhibition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297363     DOI: 10.1016/s0944-5013(01)80010-0

Source DB:  PubMed          Journal:  Microbiol Res        ISSN: 0944-5013            Impact factor:   5.415


  3 in total

1.  Formulation and Statistical Optimization of Culture Medium for Improved Production of Antimicrobial Compound by Streptomyces sp. JAJ06.

Authors:  Polpass Arul Jose; Kunjukrishnan Kamalakshi Sivakala; Solomon Robinson David Jebakumar
Journal:  Int J Microbiol       Date:  2013-12-23

2.  Optimization of the Cytotoxic Activity of Three Streptomyces Strains Isolated from Guaviare River Sediments (Colombia, South America).

Authors:  Laura Ramirez-Rodriguez; Boghos Stepanian-Martinez; Maria Morales-Gonzalez; Luis Diaz
Journal:  Biomed Res Int       Date:  2018-07-19       Impact factor: 3.411

3.  Anti-MRSA activity of a bioactive compound produced by a marine Streptomyces and its optimization using statistical experimental design.

Authors:  Hamed Norouzi; Mohammad Rabbani Khorasgani; Abolghasem Danesh
Journal:  Iran J Basic Med Sci       Date:  2019-09       Impact factor: 2.699

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.